Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Clinical aspects and immune reactions in sarcoidosis

Identifieur interne : 001B73 ( Main/Exploration ); précédent : 001B72; suivant : 001B74

Clinical aspects and immune reactions in sarcoidosis

Auteurs : Johan Grunewald [Suède]

Source :

RBID : ISTEX:D8855F6EA06FFEF69CB36EAD41CB721C845B5F54

English descriptors

Abstract

Introduction:  Sarcoidosis is a granulomatous disorder of unknown aetiology, affecting young adults and frequently involving the lungs. Objective:  The aim of the present review was to give an overview of the clinical aspects in sarcoidosis. Results:  The majority of patients recover, but some develop a chronic disease that may result in fibrosis and respiratory failure. Besides the lungs, peripheral lymph nodes, the skin, the liver and the eyes are commonly affected as well. The genetic background, as well as environmental factors, is of importance for developing sarcoidosis. The incidence varies in different populations, in the Nordic countries approximately with 20/100 000 new patients yearly. Sarcoidosis is diagnosed when clinical and radiological findings are supported by histological evidence in the form of non‐caseating epithelioid cell granulomas, and when other causes of these features are excluded. Patients in need of treatment are usually treated with corticosteroids, topically or as oral steroids. A clinical effect of immunomodulatory drugs blocking tumour necrosis factor (TNF)α has been suggested from several case reports, while two controlled studies showed only minor effects; however, with a tendency to a more pronounced effect on patients with a more severe disease. The immune response in sarcoidosis, with a typical accumulation of CD4+ T‐cells to the lungs, indicate the existence of specific antigens in this disease. Recently, antigens derived from infectious agents such as Mycobacteria and Proprionibacterium acnes have come into focus. Lymphocyte populations with immunoregulatory functions have recently been investigated and seem to be dysfunctional in sarcoidosis, opening the possibility of developing new treatment strategies in this disease. Conclusion:  Recent technical developments have provided better tools, enabling detailed and more thorough analyses of the inflammatory process in sarcoidosis. Please cite this paper as: Grunewald J. Clinical aspects and immune reactions in sarcoidosis. The Clinical Respiratory Journal 2007; 1:64–73.

Url:
DOI: 10.1111/j.1752-699X.2007.2007.00019.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Clinical aspects and immune reactions in sarcoidosis</title>
<author>
<name sortKey="Grunewald, Johan" sort="Grunewald, Johan" uniqKey="Grunewald J" first="Johan" last="Grunewald">Johan Grunewald</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D8855F6EA06FFEF69CB36EAD41CB721C845B5F54</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1111/j.1752-699X.2007.2007.00019.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-MKDM96LD-0/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000503</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000503</idno>
<idno type="wicri:Area/Istex/Curation">000503</idno>
<idno type="wicri:Area/Istex/Checkpoint">000A56</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000A56</idno>
<idno type="wicri:doubleKey">1752-6981:2007:Grunewald J:clinical:aspects:and</idno>
<idno type="wicri:Area/Main/Merge">001B84</idno>
<idno type="wicri:Area/Main/Curation">001B73</idno>
<idno type="wicri:Area/Main/Exploration">001B73</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Clinical aspects and immune reactions in sarcoidosis*</title>
<author>
<name sortKey="Grunewald, Johan" sort="Grunewald, Johan" uniqKey="Grunewald J" first="Johan" last="Grunewald">Johan Grunewald</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Medicine, Division of Respiratory Medicine, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm</wicri:regionArea>
<placeName>
<settlement type="city">Stockholm</settlement>
<region nuts="2">Svealand</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">The Clinical Respiratory Journal</title>
<title level="j" type="alt">CLINICAL RESPIRATORY JOURNAL</title>
<idno type="ISSN">1752-6981</idno>
<idno type="eISSN">1752-699X</idno>
<imprint>
<biblScope unit="vol">1</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="64">64</biblScope>
<biblScope unit="page" to="73">73</biblScope>
<biblScope unit="page-count">10</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2007-12">2007-12</date>
</imprint>
<idno type="ISSN">1752-6981</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1752-6981</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Aetiology</term>
<term>Baughman</term>
<term>Blackwell publishing</term>
<term>Bronchoalveolar</term>
<term>Bronchoalveolar lavage</term>
<term>Chemokine</term>
<term>Chronic sarcoidosis</term>
<term>Clin</term>
<term>Clinical aspects</term>
<term>Corticosteroid</term>
<term>Crit</term>
<term>Cytokine</term>
<term>Disease activity</term>
<term>Drent</term>
<term>Eklund</term>
<term>Good prognosis</term>
<term>Granuloma</term>
<term>Granulomatous</term>
<term>Grunewald</term>
<term>Immune</term>
<term>Immune response</term>
<term>Immunol</term>
<term>Issn</term>
<term>Japanese patients</term>
<term>Journal compilation</term>
<term>Lavage</term>
<term>Lymphocyte</term>
<term>Macrophage</term>
<term>Mycobacterial</term>
<term>Oral steroids</term>
<term>Pulmonary sarcoidosis</term>
<term>Receptor</term>
<term>Respir</term>
<term>Respir crit care</term>
<term>Sarcoid</term>
<term>Sarcoidosis</term>
<term>Sarcoidosis patients</term>
<term>Sarcoidosis vasc</term>
<term>Steroid</term>
<term>Thorax</term>
<term>Treg cells</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Introduction:  Sarcoidosis is a granulomatous disorder of unknown aetiology, affecting young adults and frequently involving the lungs. Objective:  The aim of the present review was to give an overview of the clinical aspects in sarcoidosis. Results:  The majority of patients recover, but some develop a chronic disease that may result in fibrosis and respiratory failure. Besides the lungs, peripheral lymph nodes, the skin, the liver and the eyes are commonly affected as well. The genetic background, as well as environmental factors, is of importance for developing sarcoidosis. The incidence varies in different populations, in the Nordic countries approximately with 20/100 000 new patients yearly. Sarcoidosis is diagnosed when clinical and radiological findings are supported by histological evidence in the form of non‐caseating epithelioid cell granulomas, and when other causes of these features are excluded. Patients in need of treatment are usually treated with corticosteroids, topically or as oral steroids. A clinical effect of immunomodulatory drugs blocking tumour necrosis factor (TNF)α has been suggested from several case reports, while two controlled studies showed only minor effects; however, with a tendency to a more pronounced effect on patients with a more severe disease. The immune response in sarcoidosis, with a typical accumulation of CD4+ T‐cells to the lungs, indicate the existence of specific antigens in this disease. Recently, antigens derived from infectious agents such as Mycobacteria and Proprionibacterium acnes have come into focus. Lymphocyte populations with immunoregulatory functions have recently been investigated and seem to be dysfunctional in sarcoidosis, opening the possibility of developing new treatment strategies in this disease. Conclusion:  Recent technical developments have provided better tools, enabling detailed and more thorough analyses of the inflammatory process in sarcoidosis. Please cite this paper as: Grunewald J. Clinical aspects and immune reactions in sarcoidosis. The Clinical Respiratory Journal 2007; 1:64–73.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Suède</li>
</country>
<region>
<li>Svealand</li>
</region>
<settlement>
<li>Stockholm</li>
</settlement>
</list>
<tree>
<country name="Suède">
<region name="Svealand">
<name sortKey="Grunewald, Johan" sort="Grunewald, Johan" uniqKey="Grunewald J" first="Johan" last="Grunewald">Johan Grunewald</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B73 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001B73 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:D8855F6EA06FFEF69CB36EAD41CB721C845B5F54
   |texte=   Clinical aspects and immune reactions in sarcoidosis
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021